Jeron Selvain Successfully Concludes 'KOREADERMA 2025', Strengthens Global Partnerships

Jeron Selvain 'Korea Derma 2025' Booth. Photo by Jeron Selvain

Jeron Selvain, a company specializing in the production of prescription pharmaceuticals, announced on November 3 that it successfully concluded its exhibition at 'KOREADERMA 2025,' held at COEX Magok.

'KOREADERMA 2025,' hosted by the Korean Dermatological Association, is one of Asia's premier dermatology symposiums, where over 5,000 dermatologists and industry professionals from more than 60 countries gather to share advancements in skin science and the latest trends.

During the conference, Jeron Selvain operated an exhibition booth and showcased its regenerative solutions and cosmetic lineup based on polynucleotides (PDRN). The company received significant attention and positive feedback from both domestic and international dermatologists and buyers.

In particular, the experience zone allowed medical professionals to explore a wide range of products, including Cellvane Injection, PN Healer for export, Cledence, the Cellvane cosmetic line, Recharge Skin Booster, Hyper Recover Ampoule, Core Revital Cream, Bio Ampoule Mask, PDRN Recover Lab, PDRN Daily Sun Cream, and Reset Booster. All of these products feature Jeron Selvain's proprietary patented 'Prism Technology Nano PDRN,' drawing considerable interest from attendees.

The company explained that its next-generation regenerative solutions, which combine skin regeneration, anti-inflammatory, and skin barrier enhancement technologies, were met with an enthusiastic response. Throughout the exhibition, there were active discussions with overseas buyers regarding business negotiations and distribution partnerships.

Kim Deokgyu, CEO of Jeron Selvain, stated, "As 'KOREADERMA 2025' is a central stage for the global medical and beauty industry, it was a meaningful opportunity to directly introduce Jeron Selvain's technological capabilities and brand philosophy. Our PDRN-based regenerative solutions serve as a platform that simultaneously enables skin damage recovery and anti-inflammatory effects, and through this exhibition, we were able to demonstrate their excellence to experts both domestically and internationally."

He added, "We will continue to develop bio-cosmetics based on scientific evidence and strengthen our presence in the global beauty and medical markets. By expanding overseas partnerships, we aim to establish ourselves as a leading brand in the K-Derma Cosmetic market."

This content was produced with the assistance of AI translation services.